Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Multiple Sclerosis News

Human Exposure To Aluminium And Multiple Sclerosis Link, Keele University

Main Category: Multiple Sclerosis
Also Included In: Neurology / Neuroscience
Article Date: 17 Feb 2006 - 13:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:5 stars

4.82 (11 votes)

Health Professional:4 stars

3.67 (6 votes)

Article Opinions: 0 posts

Scientists at Keele University in Staffordshire have discovered the first evidence of a link between human exposure to aluminium and multiple sclerosis.

Their research has demonstrated very high (up to 40 times the control level) urinary excretion of aluminium in MS, particularly so in the relapsing-remitting form of the disease. Urinary excretion of iron was also significantly elevated in MS and particularly so in the secondary progressive form of the disease.

Urinary excretion of silicon, the 'natural' antagonist to the potential toxicity of aluminium, was decreased in MS and particularly so in secondary progressive form of the disease.

The research suggests that individuals with MS have a higher body burden of aluminium and that their urinary excretion of aluminium is linked to changes taking place during the relapsing-remitting stage of the disease.

Dr Christopher Exley, Birchall Centre for Inorganic Chemistry and Materials Science, Lennard-Jones Laboratories, Keele University, Staffordshire, said: "If, as is currently believed, MS is a disorder resulting from the interplay between the environment and susceptibility genes then our observation of elevated excretion of iron may be indicative of the latter, while elevated excretion of aluminium suggests that exposure to aluminium may be the hitherto unrecognised environmental factor in MS."

Other researchers involved in the study were: Godwin Mamutse(2), Olga Korchazhkina(3), Eleanor Pye(2), Stanislav Strekopytov(1), Anthony Polwart(4), Clive Hawkins(2).

(2) - Department of Neurology, University Hospital of North Staffordshire, Keele University, Staffordshire, UK.

(3) - Institute for Science and Technology in Medicine, Keele University, Staffordshire, UK.

(4) - School of Life Sciences, Huxley Building, Keele University, Staffordshire, UK.

KEELE UNIVERSITY
Keele
Staffordshire
ST5 5BG
UK
http://www.keele.ac.uk




Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Please fill in our survey

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Hydrangea Root Shows Promise In Treating Autoimmune Disorders
05 Jun 2009
US researchers found that a drug made from the root of the hydrangea plant, which has for centuries been used in Chinese medicine, showed promising results in treating autoimmune disorders such as rheumatoid arthritis...


Talking with Your Doctor image Talking with Your Doctor

Talking with your doctor can sometimes be difficult. Good health care, however, depends on an open dialogue between patients and doctors...

An MS Drug Back on the Market image An MS Drug Back on the Market

After being suspended from the market for safety reasons, natalizumab is again available for the treatment of multiple sclerosis. Safeguards are in place because of a small risk in developing a serious brain infection. Should you consider taking this drug...

View more videos...